Safia Nawaz, MD
Allergy & Immunology · Des Moines, IANPI 1104346980
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.4%), food and beverage and education — rather than concentrated in one kind of arrangement. Sanofi accounts for 65.9% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $3,159, more than ten times the $136 reported in 2021.
Across 40 payments — averaging $87.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$2K
- Novartis$710
- Sanofi-aventis U.S. LLC$100
- ARS Pharmaceuticals Operations, Inc.$84
- AstraZeneca$71
- Amgen$70
- plus $161 from 4 others
What the payments were for
- Speaking & faculty fees$1,73449%
- Food & beverage$1,67748%
- Education$1003%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 12 | $2,316 |
| Novartis | 16 | $710 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $84 |
| AstraZeneca | 1 | $71 |
| Amgen | 1 | $70 |
| Alk-abello, Inc | 1 | $65 |
| Regeneron Healthcare Solutions, Inc. | 2 | $39 |
| Grifols USA, LLC | 2 | $37 |
| Galderma Laboratories, L.p. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$1,968
How this compares
$3,511 in reported general payments places this provider in the 75th percentile of 32 allergy & immunology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 28 | $496 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Des Moines
- Whitney MolisDes Moines$4K
- James WilleDes Moines$127
- Vuong NayimaWest Des Moines$34K
- Fadi AlkhatibWest Des Moines$16K
- Daniel HamilosMason City$11K
- Lyla SchweigerCedar Rapids$6K
- Edward NassifAmes$5K
- Holly BrownCedar Rapids$4K
- Andrea JonesDavenport$3K
- Robert SmithSioux Center$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.